FP 21399.
D019380:Anti-HIV Agents / Q000494:pharmacology*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000821:virology; D002722:Chlorobenzenes / Q000494:pharmacology*; D015507:Drugs, Investigational / Q000494:pharmacology*; D006678:HIV / Q000187:drug effects*; D015699:HIV Envelope Protein gp120 / Q000187:drug effects; D006801:Humans; D009281:Naphthalenes / Q000494:pharmacology*; D019713:Receptors, CCR5 / Q000187:drug effects
D019380:Anti-HIV Agents; D002722:Chlorobenzenes; D015507:Drugs, Investigational; D015699:HIV Envelope Protein gp120; D009281:Naphthalenes; D019713:Receptors, CCR5; C106790:FP 21399